We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current INVO market cap is 3.25M. The company's latest EPS is USD -2.0571 and P/E is -0.40.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 975k | 1.38M | 1.58M | 1.84M | 1.43M |
| Operating Income | -894k | -1.51M | -947k | -1.88M | -1.33M |
| Net Income | -1.25M | -2M | -1.6M | -2.25M | -1.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.48M | 1.04M | 4.16M | 822k | 3.02M |
| Operating Income | -1.79M | -5.52M | -5.22M | -10.63M | -6.77M |
| Net Income | -2.17M | -8.35M | -6.66M | -10.89M | -8.04M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.48M | 20.89M | 18.32M | 18.03M | 17.02M |
| Total Liabilities | 19.1M | 20M | 18.31M | 16.67M | 17.04M |
| Total Equity | 373k | 893k | 10k | 1.36M | -23k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.8M | 10.95M | 10.47M | 4.1M | 20.89M |
| Total Liabilities | 5.51M | 5.2M | 3.16M | 5.08M | 20M |
| Total Equity | -3.71M | 5.74M | 7.31M | -978k | 893k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -4.04M | -4.76M | -260k | -1.72M | -2.36M |
| Investing | -2.53M | -2.49M | -24k | -29k | -29k |
| Financing | 7.53M | 7.39M | 527k | 2.46M | 2.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.37M | -4.78M | -6.03M | -6.6M | -4.76M |
| Investing | -115k | -187k | -2.15M | -81k | -2.49M |
| Financing | -230k | 13.82M | 3.77M | 1.09M | 7.39M |
| Market Cap | 3.25M |
| Price to Earnings Ratio | -0.40 |
| Price to Sales Ratio | 1.07 |
| Price to Cash Ratio | 13.97 |
| Price to Book Ratio | 3.63 |
| Dividend Yield | - |
| Shares Outstanding | 3.91M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -33.36% |
| 52 Week High | 3.50 |
| 52 Week Low | 0.6311 |
| Spread (Intraday) | 0.01 (1.43%) |
| Company Name | INVO BioScience Inc |
| Address |
187 e warm springs road las vegas, nevada 89119 |
| Website | https://www.invobioscience.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
